Kelly Bliss - 29 Nov 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: President, U.S. Group Health
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 29 Nov 2024
Net transactions value: -$24,331
Form type: 4
Filing time: 03 Dec 2024, 17:20:12 UTC
Previous filing: 02 Oct 2024
Next filing: 04 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+1,189	+4.2%		29,392	29 Nov 2024	Direct	F1
transaction	TDOC	Common Stock	Options Exercise		+1,404	+4.8%		30,796	29 Nov 2024	Direct	F2
transaction	TDOC	Common Stock	Options Exercise		+3,488	+11%		34,284	29 Nov 2024	Direct	F2
transaction	TDOC	Common Stock	Sale	$24,331	-2,040	-6%	$11.93	32,244	02 Dec 2024	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Performance Stock Units	Options Exercise	$0	-1,189	-17%	$0.000000	5,942	29 Nov 2024	Common Stock	1,189		Direct	F1, F4
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-1,404	-50%	$0.000000	1,404	29 Nov 2024	Common Stock	1,404		Direct	F2, F5
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-3,488	-17%	$0.000000	17,440	29 Nov 2024	Common Stock	3,488		Direct	F2, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4	On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5	On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6	On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.